Alberto Soffan-feliciano, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 21 Blairs Hill Rd, Agawam, MA 01001 Phone: 413-374-2903 |
Ms. Laura Anne Santaniello, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 65 Cooper St, Agawam, MA 01001 Phone: 413-821-0749 |
Amber Dutton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 55 Elm St, Agawam, MA 01001 Phone: 413-522-5034 |
James Ndungu, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 270 Main St, Agawam, MA 01001 Phone: 413-789-0132 |
Mrs. Chantal Bernard, RN, CCM Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1125 River Rd, Agawam, MA 01001 Phone: 413-222-3098 |
John Wahlberg, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 75 Corey Colonial, Agawam, MA 01001 Phone: 860-869-3708 |
Maria Haslip, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 230 Main St, Agawam, MA 01001 Phone: 860-992-9226 |
News Archive
A selection of health policy stories from Texas, New York, Virginia, Pennsylvania, California and West Virginia.
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer.
Want to double fruit sales in schools? A new Cornell University study shows it is as easy as putting the fruit in a colorful bowl. According to research presented this week at the American Dietetic Association Conference in San Diego, CA by Brian Wansink, Professor at Cornell University, "Moving the fruit increased sales by 104%."
Scientists from Salk Institute (USA), Skoltech (Russia), and Riken Center for Brain Science (Japan) investigated a theoretical model of how populations of neurons in the visual cortex of the brain may recognize and process faces and their different expressions and how they are organized.
TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications.
› Verified 9 days ago